HEADER    HYDROLASE INHIBITOR                     08-NOV-00   1G6X              
TITLE     ULTRA HIGH RESOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR
TITLE    2 (BPTI) MUTANT WITH ALTERED BINDING LOOP SEQUENCE                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PANCREATIC TRYPSIN INHIBITOR;                              
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: BPTI, APROTININ, TRASYLOL, BASIC PROTEASE INHIBITOR;        
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: BOS TAURUS;                                     
SOURCE   3 ORGANISM_COMMON: CATTLE;                                             
SOURCE   4 ORGANISM_TAXID: 9913;                                                
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS;                          
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PAED4                                     
KEYWDS    SERINE PROTEASE INHIBITOR, HYDROLASE INHIBITOR                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    A.ADDLAGATTA,H.CZAPINSKA,S.KRZYWDA,J.OTLEWSKI,M.JASKOLSKI             
REVDAT   5   27-OCT-21 1G6X    1       REMARK SEQADV                            
REVDAT   4   13-JUL-11 1G6X    1       VERSN                                    
REVDAT   3   24-FEB-09 1G6X    1       VERSN                                    
REVDAT   2   01-APR-03 1G6X    1       JRNL                                     
REVDAT   1   09-MAY-01 1G6X    0                                                
JRNL        AUTH   A.ADDLAGATTA,S.KRZYWDA,H.CZAPINSKA,J.OTLEWSKI,M.JASKOLSKI    
JRNL        TITL   ULTRAHIGH-RESOLUTION STRUCTURE OF A BPTI MUTANT.             
JRNL        REF    ACTA CRYSTALLOGR.,SECT.D      V.  57   649 2001              
JRNL        REFN                   ISSN 0907-4449                               
JRNL        PMID   11320305                                                     
JRNL        DOI    10.1107/S0907444901003468                                    
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   H.CZAPINSKA,J.OTLEWSKI,S.KRZYWDA,G.M.SHELDRICK,M.JASKOLSKI   
REMARK   1  TITL   HIGH-RESOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN       
REMARK   1  TITL 2 INHIBITOR WITH ALTERED BINDING LOOP SEQUENC                  
REMARK   1  REF    J.MOL.BIOL.                   V. 295  1237 2000              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   1  DOI    10.1006/JMBI.1999.3445                                       
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   S.PARKIN,B.RUPP,H.HOPE                                       
REMARK   1  TITL   STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT 125 K:   
REMARK   1  TITL 2 DEFINITION OF CARBOXYL-TERMINAL RESIDUES GLY57 AND ALA58     
REMARK   1  REF    ACTA CRYSTALLOGR.,SECT.D      V.  52    19 1996              
REMARK   1  REFN                   ISSN 0907-4449                               
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   K.BERNDT,P.GUENTERT,L.P.ORBONS,K.WUETHRICH                   
REMARK   1  TITL   DETERMINATION OF A HIGH QUALITY NUCLEAR MAGNETIC RESONANCE   
REMARK   1  TITL 2 SOLUTION STRUCTURE OF THE BOVINE PANCREATIC TRYPSIN          
REMARK   1  TITL 3 INHIBITOR AND COMPARISON WITH THREE CRYSTAL STRUCTURES       
REMARK   1  REF    J.MOL.BIOL.                   V. 227   757 1992              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   1 REFERENCE 4                                                          
REMARK   1  AUTH   A.WLODAWER,J.WALTER,R.HUBER,L.SJOLIN                         
REMARK   1  TITL   STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR . RESULTS   
REMARK   1  TITL 2 OF JOINT NEUTRON AND X-RAY REFINEMENT OF CRYSTAL FORM II     
REMARK   1  REF    J.MOL.BIOL.                   V. 180   301 1984              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   1 REFERENCE 5                                                          
REMARK   1  AUTH   J.DEISENHOFER,W.STEIGEMANN                                   
REMARK   1  TITL   CRYSTALLOGRAPHIC REFINEMENT OF THE STRUCTURE OF BOVINE       
REMARK   1  TITL 2 PANCREATIC TRYPSIN INHIBITOR AT 1.5 A RESOLUTION             
REMARK   1  REF    ACTA CRYSTALLOGR.,SECT.B      V.  31   238 1975              
REMARK   1  REFN                   ISSN 0108-7681                               
REMARK   1  DOI    10.1107/S0567740875002415                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    0.86 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 0.86                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 10.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 94.9                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.107                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.107                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.140                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 1883                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 46998                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.104                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.104                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.137                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 1706                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 42585                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 452                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 44                                            
REMARK   3   SOLVENT ATOMS      : 170                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 603.00                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 426.00                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 12                      
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 6499                    
REMARK   3   NUMBER OF RESTRAINTS                     : 7361                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.023                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.043                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL                    
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.035                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.060                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.083                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.081                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.007                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.041                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.094                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228        
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: ETHYLENE GLYCOL (EDO) AND SULFATE (SO4) GEOMETRY     
REMARK   3                 BASED ON DATA FROM CSD                               
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT WITHOUT            
REMARK   3  STEREOCHEMICAL RESTRAINTS ON ORDERED MAIN CHAIN. THE COMPLETE C-    
REMARK   3  TERMINUS IS VISIBLE. IT FORMS A SALT-BRIDGE WITH THE N-TERMINUS.    
REMARK   3  ARG 39 IS DISORDERED IN TWO CONFORMATIONS. IN ADDITION, IT IS       
REMARK   3  ADJACENT TO CYS 38 OF THE DISORDERED 14-38 DISULFIDE AND IS PART    
REMARK   3  OF A DISORDERED ARGININE CAGE. ALA 58 IS THE C-TERMINAL RESIDUE.    
REMARK   3  IT IMMEDIATELY FOLLOWS THE DISORDERED GLY 56 - GLY 57 DOUBLET.      
REMARK   3  THE CYS14-CYS38 DISULFIDE BRIDGE IS OBSERVED IN TWO DISTINCT        
REMARK   3  CHIRALITIES (60 % RIGHT-HANDED, 40 % LEFT-HANDED). THE MAIN         
REMARK   3  CHAIN OF THREE RESIDUES AND THE SIDE CHAINS OF 10 RESIDUES ARE      
REMARK   3  MODELED IN TWO CONFORMATIONS. EIGHT SULFATE ANIONS (TWO WITH TWO-   
REMARK   3  FOLD SYMMETRY) ARE PRESENT IN THE ASYMMETRIC UNIT. ONE OF THEM      
REMARK   3  SHARES A SITE WITH THREE WATER MOLECULES. TWO ETHYLENE GLYCOL       
REMARK   3  MOLECULES MODELED PER ONE PROTEIN MOLECULE. REFINEMENT CONCLUDED    
REMARK   3  USING ONE CYCLE OF BLOCKED FULL-MATRIX LEAST-SQUARES ALGORITHM.     
REMARK   4                                                                      
REMARK   4 1G6X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-NOV-00.                  
REMARK 100 THE DEPOSITION ID IS D_1000012309.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 07-JUL-99                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : EMBL/DESY, HAMBURG                 
REMARK 200  BEAMLINE                       : X11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9090                             
REMARK 200  MONOCHROMATOR                  : SI                                 
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 47018                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 0.860                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 20.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -3.000                             
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 94.9                               
REMARK 200  DATA REDUNDANCY                : 17.30                              
REMARK 200  R MERGE                    (I) : 0.03600                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 54.1000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.86                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 0.90                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 88.6                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 6.00                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.48800                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 3.610                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: EXISTING MODEL               
REMARK 200 SOFTWARE USED: SHELX                                                 
REMARK 200 STARTING MODEL: 1QLQ                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 46.00                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 2% PEG 400, 2 M AMMONIUM SULFATE, 0.1    
REMARK 280  M NA HEPES. A PROTEIN SAMPLE, LYOPHILIZED AFTER HPLC                
REMARK 280  PURIFICATION FROM TFA/ACETONITRILE MIXTURE, WAS DISSOLVED IN        
REMARK 280  WATER TO A CONCENTRATION OF 9 MG/2 UL DROPS OF THE PROTEIN          
REMARK 280  SOLUTION WERE MIXED WITH 2 UL OF RESERVOIR SOLUTION CONTAINING 2%   
REMARK 280  PEG 400, 2 M AMMONIUM SULFATE AND 0.1 M NA HEPES, PH 7.5. THE       
REMARK 280  HANGING DROPLETS WERE EQUILIBRATED AT 19 DEG C THROUGH THE GAS      
REMARK 280  PHASE WITH THE RESERVOIR. PRISMATIC CRYSTALS MEASURING UP TO 0.4    
REMARK 280  MM GREW WITHIN 12 HOURS. FOR LOW-TEMPERATURE DATA COLLECTION        
REMARK 280  (100 K), THE CRYSTAL WAS CRYOPROTECTED IN THE RESERVOIR SOLUTION    
REMARK 280  SUPPLEMENTED BY 30 % ETHYLENE GLYCOL., VAPOR DIFFUSION, HANGING     
REMARK 280  DROP, TEMPERATURE 292K                                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2                        
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z+1/2                                             
REMARK 290       3555   -Y+1/2,X+1/2,Z+3/4                                      
REMARK 290       4555   Y+1/2,-X+1/2,Z+1/4                                      
REMARK 290       5555   -X+1/2,Y+1/2,-Z+3/4                                     
REMARK 290       6555   X+1/2,-Y+1/2,-Z+1/4                                     
REMARK 290       7555   Y,X,-Z                                                  
REMARK 290       8555   -Y,-X,-Z+1/2                                            
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       21.51750            
REMARK 290   SMTRY1   3  0.000000 -1.000000  0.000000       25.94550            
REMARK 290   SMTRY2   3  1.000000  0.000000  0.000000       25.94550            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       32.27625            
REMARK 290   SMTRY1   4  0.000000  1.000000  0.000000       25.94550            
REMARK 290   SMTRY2   4 -1.000000  0.000000  0.000000       25.94550            
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       10.75875            
REMARK 290   SMTRY1   5 -1.000000  0.000000  0.000000       25.94550            
REMARK 290   SMTRY2   5  0.000000  1.000000  0.000000       25.94550            
REMARK 290   SMTRY3   5  0.000000  0.000000 -1.000000       32.27625            
REMARK 290   SMTRY1   6  1.000000  0.000000  0.000000       25.94550            
REMARK 290   SMTRY2   6  0.000000 -1.000000  0.000000       25.94550            
REMARK 290   SMTRY3   6  0.000000  0.000000 -1.000000       10.75875            
REMARK 290   SMTRY1   7  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY2   7  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   8  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY2   8 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000       21.51750            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 4390 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 7410 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -182.0 KCAL/MOL                       
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2  0.000000 -1.000000  0.000000       51.89100            
REMARK 350   BIOMT2   2 -1.000000  0.000000  0.000000       51.89100            
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000       21.51750            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375 S    SO4 A  64  LIES ON A SPECIAL POSITION.                          
REMARK 375 S    SO4 A  65  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 121  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 133  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 164  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 203  LIES ON A SPECIAL POSITION.                          
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A   1   NE  -  CZ  -  NH1 ANGL. DEV. =   5.4 DEGREES          
REMARK 500    ARG A   1   NE  -  CZ  -  NH1 ANGL. DEV. =   7.9 DEGREES          
REMARK 500    ARG A   1   NE  -  CZ  -  NH2 ANGL. DEV. =  -9.0 DEGREES          
REMARK 500    ARG A   1   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.3 DEGREES          
REMARK 500    ARG A  15   NH1 -  CZ  -  NH2 ANGL. DEV. =   6.8 DEGREES          
REMARK 500    ARG A  15   NE  -  CZ  -  NH1 ANGL. DEV. =   7.2 DEGREES          
REMARK 500    ARG A  15   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.9 DEGREES          
REMARK 500    ARG A  17   CD  -  NE  -  CZ  ANGL. DEV. =  14.6 DEGREES          
REMARK 500    ARG A  17   NE  -  CZ  -  NH1 ANGL. DEV. =  10.0 DEGREES          
REMARK 500    ARG A  17   NE  -  CZ  -  NH1 ANGL. DEV. =  -7.2 DEGREES          
REMARK 500    ARG A  17   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.9 DEGREES          
REMARK 500    ARG A  17   NE  -  CZ  -  NH2 ANGL. DEV. =   8.1 DEGREES          
REMARK 500    CYS A  38   CB  -  CA  -  C   ANGL. DEV. =   7.5 DEGREES          
REMARK 500    ARG A  39   CD  -  NE  -  CZ  ANGL. DEV. =  12.1 DEGREES          
REMARK 500    ARG A  39   CD  -  NE  -  CZ  ANGL. DEV. =  22.0 DEGREES          
REMARK 500    ARG A  39   NE  -  CZ  -  NH1 ANGL. DEV. =   7.2 DEGREES          
REMARK 500    ARG A  39   NE  -  CZ  -  NH1 ANGL. DEV. =   3.7 DEGREES          
REMARK 500    ARG A  39   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.1 DEGREES          
REMARK 500    ARG A  53   NE  -  CZ  -  NH2 ANGL. DEV. =  -5.5 DEGREES          
REMARK 500    ALA A  58   C   -  N   -  CA  ANGL. DEV. =  20.1 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A  44      106.37   -161.82                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 GLY A   57     ALA A   58                  145.63                    
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 610                                                                      
REMARK 610 MISSING HETEROATOM                                                   
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 610 I=INSERTION CODE):                                                   
REMARK 610   M RES C SSEQI                                                      
REMARK 610     SO4 A   64                                                       
REMARK 610     SO4 A   65                                                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 61                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 62                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 63                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 64                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC5                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 65                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC6                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 66                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC7                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 68                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC8                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 67                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC9                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 81                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: BC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 82                  
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1QLQ   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT (THR 11 REPLACED   
REMARK 900 BY ALA, PRO 13 REPLACED BY ALA, LYS 15 REPLACED BY ARG, MET 52       
REMARK 900 REPLACED BY LEU)                                                     
REMARK 900 RELATED ID: 4PTI   RELATED DB: PDB                                   
REMARK 900 TRYPSIN INHIBITOR                                                    
REMARK 900 RELATED ID: 5PTI   RELATED DB: PDB                                   
REMARK 900 TRYPSIN INHIBITOR (CRYSTAL FORM II)                                  
REMARK 900 RELATED ID: 6PTI   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI, CRYSTAL FORM III)         
REMARK 900 RELATED ID: 7PTI   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT (CYS 30 REPLACED   
REMARK 900 BY ALA, CYS 51 REPLACED BY ALA)                                      
REMARK 900 RELATED ID: 8PTI   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT (TYR 35 REPLACED   
REMARK 900 BY GLY)                                                              
REMARK 900 RELATED ID: 9PTI   RELATED DB: PDB                                   
REMARK 900 BASIC PANCREATIC TRYPSIN INHIBITOR (MET 52 OXIDIZED)                 
REMARK 900 RELATED ID: 1AAL   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI, BASIC) MUTANT WITH CYS    
REMARK 900 30 REPLACED BY VAL AND CYS 51 REPLACED BY ALA                        
REMARK 900 RELATED ID: 1BPT   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT (TYR 23 REPLACED   
REMARK 900 BY ALA)                                                              
REMARK 900 RELATED ID: 1BTI   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH PHE 22        
REMARK 900 REPLACED BY ALA                                                      
REMARK 900 RELATED ID: 1FAN   RELATED DB: PDB                                   
REMARK 900 BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH PHE 45        
REMARK 900 REPLACED BY ALA                                                      
DBREF  1G6X A    1    58  UNP    P00974   BPT1_BOVIN      36     93             
SEQADV 1G6X ALA A   11  UNP  P00974    THR    46 ENGINEERED MUTATION            
SEQADV 1G6X ALA A   13  UNP  P00974    PRO    48 ENGINEERED MUTATION            
SEQADV 1G6X ARG A   15  UNP  P00974    LYS    50 ENGINEERED MUTATION            
SEQADV 1G6X LEU A   52  UNP  P00974    MET    87 ENGINEERED MUTATION            
SEQRES   1 A   58  ARG PRO ASP PHE CYS LEU GLU PRO PRO TYR ALA GLY ALA          
SEQRES   2 A   58  CYS ARG ALA ARG ILE ILE ARG TYR PHE TYR ASN ALA LYS          
SEQRES   3 A   58  ALA GLY LEU CYS GLN THR PHE VAL TYR GLY GLY CYS ARG          
SEQRES   4 A   58  ALA LYS ARG ASN ASN PHE LYS SER ALA GLU ASP CYS LEU          
SEQRES   5 A   58  ARG THR CYS GLY GLY ALA                                      
HET    SO4  A  61       5                                                       
HET    SO4  A  62       5                                                       
HET    SO4  A  63       5                                                       
HET    SO4  A  64       3                                                       
HET    SO4  A  65       3                                                       
HET    SO4  A  66       5                                                       
HET    SO4  A  68       5                                                       
HET    SO4  A  67       5                                                       
HET    EDO  A  81       4                                                       
HET    EDO  A  82       4                                                       
HETNAM     SO4 SULFATE ION                                                      
HETNAM     EDO 1,2-ETHANEDIOL                                                   
HETSYN     EDO ETHYLENE GLYCOL                                                  
FORMUL   2  SO4    8(O4 S 2-)                                                   
FORMUL  10  EDO    2(C2 H6 O2)                                                  
FORMUL  12  HOH   *170(H2 O)                                                    
HELIX    1   1 PRO A    2  GLU A    7  5                                   6    
HELIX    2   2 SER A   47  GLY A   56  1                                  10    
SHEET    1   A 2 ILE A  18  ASN A  24  0                                        
SHEET    2   A 2 LEU A  29  TYR A  35 -1  O  LEU A  29   N  ASN A  24           
SSBOND   1 CYS A    5    CYS A   55                          1555   1555  2.04  
SSBOND   2 CYS A   14    CYS A   38                          1555   1555  1.86  
SSBOND   3 CYS A   30    CYS A   51                          1555   1555  2.06  
SITE     1 AC1 11 GLU A   7  LYS A  41  ARG A  42  HOH A 106                    
SITE     2 AC1 11 HOH A 123  HOH A 135  HOH A 138  HOH A 140                    
SITE     3 AC1 11 HOH A 160  HOH A 257  HOH A 258                               
SITE     1 AC2 12 ARG A  20  TYR A  35  GLY A  37  ALA A  40                    
SITE     2 AC2 12 ARG A  53  HOH A 122  HOH A 175  HOH A 206                    
SITE     3 AC2 12 HOH A 218  HOH A 220  HOH A 221  HOH A 223                    
SITE     1 AC3  9 ARG A   1  PRO A   2  ARG A  42  HOH A 115                    
SITE     2 AC3  9 HOH A 132  HOH A 167  HOH A 173  HOH A 194                    
SITE     3 AC3  9 HOH A 259                                                     
SITE     1 AC4  7 CYS A  14  ARG A  15  HOH A 163  HOH A 250                    
SITE     2 AC4  7 HOH A 252  HOH A 253  HOH A 254                               
SITE     1 AC5  5 PRO A   2  ASP A   3  HOH A 115  HOH A 194                    
SITE     2 AC5  5 HOH A 195                                                     
SITE     1 AC6  7 CYS A  38  ARG A  39  HOH A 122  HOH A 170                    
SITE     2 AC6  7 HOH A 215  HOH A 221  HOH A 251                               
SITE     1 AC7  2 ARG A   1  LYS A  26                                          
SITE     1 AC8  7 PRO A   9  TYR A  10  ALA A  11  GLY A  12                    
SITE     2 AC8  7 HOH A 168  HOH A 169  HOH A 232                               
SITE     1 AC9  7 TYR A  10  ARG A  39  ALA A  40  LYS A  41                    
SITE     2 AC9  7 HOH A 123  HOH A 152  HOH A 172                               
SITE     1 BC1  5 ALA A  25  LEU A  52  GLY A  56  HOH A 200                    
SITE     2 BC1  5 HOH A 201                                                     
CRYST1   51.891   51.891   43.035  90.00  90.00  90.00 P 43 21 2     8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.019271  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.019271  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.023237        0.00000                         
ATOM      2  CA  ARG A   1      39.573  19.731   8.321  1.00 15.12           C  
ANISOU    2  CA  ARG A   1     2208   1635   1901   -267   -385    257       C  
ATOM     18  CA  PRO A   2      38.027  18.398   9.741  1.00 10.77           C  
ANISOU   18  CA  PRO A   2     1344   1397   1351    113   -146    -55       C  
ATOM     25  CA  ASP A   3      36.833  19.938  13.754  1.00 10.87           C  
ANISOU   25  CA  ASP A   3     1278   1322   1531    239   -107   -299       C  
ATOM     33  CA  PHE A   4      39.177  17.376  15.988  1.00  8.92           C  
ANISOU   33  CA  PHE A   4     1049   1184   1154     84    110   -143       C  
ATOM     44  CA  CYS A   5      43.239  18.027  14.269  1.00  8.70           C  
ANISOU   44  CA  CYS A   5     1097   1080   1129     60     91    -86       C  
ATOM     50  CA  LEU A   6      42.273  21.810  16.405  1.00  9.61           C  
ANISOU   50  CA  LEU A   6     1382   1047   1224     12     26   -130       C  
ATOM     58  CA  GLU A   7      42.216  19.810  18.685  1.00  9.66           C  
ANISOU   58  CA  GLU A   7     1511    996   1162    127     60   -178       C  
ATOM     67  CA  PRO A   8      45.327  20.714  22.153  1.00 10.40           C  
ANISOU   67  CA  PRO A   8     1720   1100   1131     75   -217    -83       C  
ATOM     74  CA  PRO A   9      47.724  17.092  23.199  1.00 10.31           C  
ANISOU   74  CA  PRO A   9     1683   1188   1046    204     10      1       C  
ATOM     81  CA  TYR A  10      45.924  15.049  24.243  1.00 10.20           C  
ANISOU   81  CA  TYR A  10     1643   1252    981    331    176     45       C  
ATOM     93  CA  ALA A  11      49.656  11.825  25.311  1.00 11.17           C  
ANISOU   93  CA  ALA A  11     1572   1612   1061    389    180     90       C  
ATOM     98  CA  GLY A  12      45.592  10.403  28.316  1.00 13.38           C  
ANISOU   98  CA  GLY A  12     1878   1964   1243    577    377    411       C  
ATOM    102  CA  ALA A  13      47.417   8.752  31.914  1.00 15.30           C  
ANISOU  102  CA  ALA A  13     2397   2253   1166    596    432    432       C  
ATOM    107  CA  CYS A  14      49.814   6.265  30.473  1.00 15.65           C  
ANISOU  107  CA  CYS A  14     2177   2602   1166    811    493    604       C  
ATOM    113  CA  ARG A  15      53.173   5.791  29.936  1.00 22.91           C  
ANISOU  113  CA  ARG A  15     2311   4877   1517   1184    252    889       C  
ATOM    130  CA  ALA A  16      53.684   3.786  27.395  1.00 19.63           C  
ANISOU  130  CA  ALA A  16     2171   3546   1741   1505    570    947       C  
ATOM    135  CA  ARG A  17      56.331   6.676  24.916  1.00 15.75           C  
ANISOU  135  CA  ARG A  17     2055   2589   1340   1215     90    304       C  
ATOM    152  CA  ILE A  18      55.457   6.987  22.075  1.00 12.38           C  
ANISOU  152  CA  ILE A  18     1706   1661   1336    713    238    249       C  
ATOM    160  CA  ILE A  19      56.472   8.719  19.182  1.00 10.53           C  
ANISOU  160  CA  ILE A  19     1302   1487   1211    384     56     64       C  
ATOM    168  CA  ARG A  20      54.301  10.316  18.170  1.00  9.09           C  
ANISOU  168  CA  ARG A  20     1252   1174   1029    152     23    -28       C  
ATOM    179  CA  TYR A  21      52.089  13.223  15.232  1.00  8.32           C  
ANISOU  179  CA  TYR A  21     1046   1074   1042     13     18     24       C  
ATOM    191  CA  PHE A  22      49.855  15.648  15.884  1.00  8.60           C  
ANISOU  191  CA  PHE A  22     1036   1098   1133      7     17     -1       C  
ATOM    202  CA  TYR A  23      48.084  18.163  13.625  1.00  8.66           C  
ANISOU  202  CA  TYR A  23     1043   1150   1097    -13     82     55       C  
ATOM    214  CA  ASN A  24      49.754  23.067  15.720  1.00  9.98           C  
ANISOU  214  CA  ASN A  24     1400   1169   1224     -2    279   -110       C  
ATOM    222  CA  ALA A  25      45.649  24.779  14.870  1.00 14.55           C  
ANISOU  222  CA  ALA A  25     1405   1977   2148    579    229   -100       C  
ATOM    227  CA  LYS A  26      48.466  27.927  16.258  1.00 16.35           C  
ANISOU  227  CA  LYS A  26     2883   1594   1735    656    156   -178       C  
ATOM    240  CA  ALA A  27      51.518  25.659  13.806  1.00 14.00           C  
ANISOU  240  CA  ALA A  27     2048   1321   1952   -322     17    -90       C  
ATOM    245  CA  GLY A  28      49.377  24.340  10.791  1.00 11.84           C  
ANISOU  245  CA  GLY A  28     1392   1637   1469    232    162    160       C  
ATOM    250  CA ALEU A  29      51.589  21.449  12.114  0.49 11.21           C  
ANISOU  250  CA ALEU A  29     1303   1167   1791   -158    454    -12       C  
ATOM    251  CA BLEU A  29      51.589  21.449  12.114  0.51 11.19           C  
ANISOU  251  CA BLEU A  29     1436   1200   1615     56    569    131       C  
ATOM    265  CA  CYS A  30      50.932  18.209  12.550  1.00  9.33           C  
ANISOU  265  CA  CYS A  30     1126   1166   1251    -51     38    -83       C  
ATOM    271  CA  GLN A  31      55.685  17.987  14.661  1.00  9.65           C  
ANISOU  271  CA  GLN A  31     1076   1346   1244    -48     16   -146       C  
ATOM    280  CA  THR A  32      54.649  14.797  16.325  1.00 10.58           C  
ANISOU  280  CA  THR A  32     1276   1396   1348     54    -86   -222       C  
ATOM    287  CA  PHE A  33      54.568  14.474  21.297  1.00 10.90           C  
ANISOU  287  CA  PHE A  33     1393   1521   1226     57   -138   -228       C  
ATOM    298  CA  VAL A  34      54.802  13.370  23.628  1.00 12.64           C  
ANISOU  298  CA  VAL A  34     1644   1996   1163    412   -104     54       C  
ATOM    305  CA  TYR A  35      52.632   8.863  24.069  1.00 11.65           C  
ANISOU  305  CA  TYR A  35     1645   1680   1101    650    153    169       C  
ATOM    317  CA  GLY A  36      51.945   7.569  25.975  1.00 13.45           C  
ANISOU  317  CA  GLY A  36     1836   2065   1210    827    271    414       C  
ATOM    321  CA  GLY A  37      50.058   3.975  24.650  1.00 14.76           C  
ANISOU  321  CA  GLY A  37     2277   1759   1573    827    547    418       C  
ATOM    325  CA  CYS A  38      45.372   3.266  25.404  1.00 14.85           C  
ANISOU  325  CA  CYS A  38     2119   1748   1777    536    448    697       C  
ATOM    333  CA  ARG A  39      42.430   5.893  27.075  1.00 13.45           C  
ANISOU  333  CA  ARG A  39     1879   1760   1471    482    479    596       C  
ATOM    350  CA  ALA A  40      44.066   9.068  23.140  1.00 10.56           C  
ANISOU  350  CA  ALA A  40     1650   1240   1120    224    158    143       C  
ATOM    355  CA  LYS A  41      41.776  11.206  20.990  1.00  9.18           C  
ANISOU  355  CA  LYS A  41     1285   1160   1043    102    154     80       C  
ATOM    364  CA  ARG A  42      42.159  10.782  17.202  1.00  8.49           C  
ANISOU  364  CA  ARG A  42     1213   1032    979    -21    121    -58       C  
ATOM    375  CA  ASN A  43      43.138  14.196  16.776  1.00  8.14           C  
ANISOU  375  CA  ASN A  43     1092   1068    932     31    134     63       C  
ATOM    383  CA  ASN A  44      46.558  12.274  16.961  1.00  8.53           C  
ANISOU  383  CA  ASN A  44     1163   1082    997    113    150     11       C  
ATOM    391  CA  PHE A  45      48.694  10.257  13.966  1.00  8.35           C  
ANISOU  391  CA  PHE A  45     1151   1053    968    -55    149    -63       C  
ATOM    402  CA  LYS A  46      50.481   7.069  13.530  1.00  9.52           C  
ANISOU  402  CA  LYS A  46     1404   1024   1191    135    288     87       C  
ATOM    414  CA  SER A  47      52.550   9.432  11.311  1.00  9.77           C  
ANISOU  414  CA  SER A  47     1251   1226   1234     75    275    147       C  
ATOM    420  CA  ALA A  48      54.312  12.829  10.162  1.00  9.26           C  
ANISOU  420  CA  ALA A  48     1172   1238   1109    -61    139    144       C  
ATOM    425  CA  GLU A  49      51.010  12.530   5.969  1.00 10.08           C  
ANISOU  425  CA  GLU A  49     1298   1441   1089    -40    258      2       C  
ATOM    434  CA  ASP A  50      49.009  10.798   6.147  1.00  9.36           C  
ANISOU  434  CA  ASP A  50     1199   1224   1133   -170    119    -79       C  
ATOM    445  CA  CYS A  51      47.666  14.395  10.103  1.00  8.38           C  
ANISOU  445  CA  CYS A  51     1071   1161    953    -51    155    -36       C  
ATOM    451  CA  LEU A  52      49.708  15.521   7.475  1.00  9.16           C  
ANISOU  451  CA  LEU A  52     1095   1255   1130    -82     40     92       C  
ATOM    459  CA  ARG A  53      45.658  14.398   4.884  1.00 10.53           C  
ANISOU  459  CA  ARG A  53     1186   1780   1033      6     44   -198       C  
ATOM    476  CA  THR A  54      42.951  14.450   7.335  1.00  9.33           C  
ANISOU  476  CA  THR A  54     1100   1346   1100    -50     28    -86       C  
ATOM    483  CA  CYS A  55      44.967  16.508   7.711  1.00  9.91           C  
ANISOU  483  CA  CYS A  55     1187   1431   1148    102    -13   -228       C  
ATOM    490  CA AGLY A  56      46.393  20.407   5.734  0.46 12.07           C  
ANISOU  490  CA AGLY A  56     1650   1458   1479     47    101     72       C  
ATOM    491  CA BGLY A  56      46.393  20.407   5.734  0.54 11.68           C  
ANISOU  491  CA BGLY A  56     1421   1353   1664    -91     52     57       C  
ATOM    498  CA AGLY A  57      43.698  20.678   4.588  0.53 20.16           C  
ANISOU  498  CA AGLY A  57     1741   3324   2593    171   -201    907       C  
ATOM    499  CA BGLY A  57      43.698  20.678   4.588  0.47 20.25           C  
ANISOU  499  CA BGLY A  57     2082   3260   2353    -36     15   1044       C  
ATOM    505  CA  ALA A  58      42.463  24.117   5.470  1.00 34.03           C  
ANISOU  505  CA  ALA A  58     3921   3637   5370   1039    681   1479       C  
TER     506      ALA A  58                                                      
END                                                                             
